NCT07170852View on ClinicalTrials.gov

Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

June 16, 2025

Study Completion Date

August 21, 2025

Conditions

Hypercholesterolaemia

Interventions

DRUG

Bempedoic acid film coated tablet

1 tablet of 180 mg Bempedoic Acid

DRUG

Nilemdo® Film-coated tablets

1 tablet of 180 mg Bempedoic Acid

Trial Locations (1)

201301

Cliantha Research Limited, Noida

All Listed Sponsors

lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT07170852 - Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets | Biotech Hunter | Biotech Hunter